Unconventional indicators of drug dependence among elderly long-term users of benzodiazepines

Issues in Mental Health Nursing

Volumn 25, Issue 6, 2004, Pages 603-628

  Voyer, Philippe ^a,b   McCubbin, Michael ^a,c   Cohen, David ^d   Lauzon, Sylvie ^e   Collin, Johanne ^f   Boivin, Caroline ^b  

^a UNIVERSITÉ LAVAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c CLSC   (Canada)

^d FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^e UNIVERSITY OF OTTAWA   (Canada)

^f UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE;

AGED; CONTROLLED STUDY; DISEASE MARKER; DRUG DEPENDENCE; DRUG DOSE REDUCTION; FEMALE; GROUPS BY AGE; HUMAN; LONG TERM CARE; MALE; POPULATION RESEARCH; PRESCRIPTION; REVIEW;

ACTIVITIES OF DAILY LIVING; ADAPTATION, PSYCHOLOGICAL; AGED; ANTI-ANXIETY AGENTS; ATTITUDE TO HEALTH; BENZODIAZEPINES; DENIAL (PSYCHOLOGY); DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HEALTH BEHAVIOR; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INTERVIEW, PSYCHOLOGICAL; MALE; NEEDS ASSESSMENT; QUEBEC; QUESTIONNAIRES; RISK FACTORS; SUBSTANCE-RELATED DISORDERS; TIME FACTORS;

EID: 4344578089     PISSN: 01612840     EISSN: None     Source Type: Journal    
DOI: 10.1080/01612840490472138     Document Type: Review

References (96)

1. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., text rev.) Washington, DC: Author.
2. Ankri, J., Collin, J., Pérodeau, G., & Beaufils, B. (2002). Médicaments psychotropes et sujets âgés: Une problématique commune France-Québec? (Synthèse de la littérature) [Psychotropic drugs and elderly subjects: A similar problem in France and Quebec? Review of the literature]. Sciences sociales et santé, 20(1), 35-62.
3. Aparasu, R. R., Mort, J. R., & Sitzman, S. (1998). Psychotropic prescribing for the elderly in office-based practice. Clinical Therapy, 20, 603-616.
4. Baillargon, L., Landreville, P., Verreault, R., Beauchemin, J. P., Grégoire, J. P., & Morin, C. M. (2003). Discontinuation of benzodiazepines among older insomniac adults treated with cognitive-behavioral therapy combined with gradual tapering: A randomized trial. Canadian Medical Association Journal, 169(10), 1015-1020.
5. Baker, R., & Shaw, E. J. (2001). Audit protocol: Benzodiazepine prescribing in Primary Care. CT17. Leicester: Clinical Governance Research & Development Unit, Department of General Practice & Primary Health Care, University of Leicester.
6. Barbone, F., McMahon, A. D., Davey, P. G., Morris, A. D., Reid, I. C., McDevitt, D. G., & MacDonald, T. M. (1998). Association of road-traffic accidents with benzodiazepine use. Lancet, 352, 1331-1336.
7. Barry, P. P., & Ackerman, K. (1999). Chemical dependency in the elderly. In W. R. Hazzard, J. P. Blass, W. H. Ettinger, J. B. Halter, & J. G. Ouslander (Eds.), Principles of geriatric medicine and gerontology (pp. 1357-1363). Montreal: McGraw-Hill.
8. Barter, G., & Cormack, M. (1996). The long-term use of benzodiazepine: Patients' views, accounts and experiences. Family Practice, 13, 491-497.
9. Benkert, O., Graf-Morgenstern, M., Hillert, A., & Sandmann, J. (1997). Public opinion on psychotropic drugs: An analysis of the factors influencing acceptance or rejection. The Journal of Nervous and Mental Disease, 185, 151-158.
10. Berg, S., & Dellasega, C. (1996). The use of psychoactive medications and cognitive function in older adults. Journal of Aging and Health, 8, 136-149.
11. Blazer, D., Hybels, C., Simonsick, E. M., & Hanlon, J. T. (2000). Marked differences in antidepressant use by race in an elderly community sample: 1986-1996. American Journal of Psychiatry, 157, 1089-1094.
12. Bridges-Webb, C., Mant, A., & Britt, H. (1985). Long term psychotropic drug prescription for general practice patients. Family Practice, 2, 238-240.
13. Canadian Pharmaceutical Association. (1998). Canadian compendium of pharmaceuticals and specialties (33rd ed.). Ottawa: Author.
14. Chaimowicz, F., Ferreira, T. de J. X. M., & Miguel, D. F. A. (2000). Use of psychoactive drugs and related falls among older people living in a community in Brazil. Revista de Saúde Pública, 34, 631-635.
15. Closser, M. H. (1991). Benzodiazepines and the elderly: A review of potential problems. Journal of Substance Abuse Treatment, 8, 35-41.
16. Cohen, D., & Collin, J. (2000). Les toxicomanies en lien avec les médicaments psychotropes chez, les personnes âgées, les femmes et les enfants: Recension et analyse des écrits [Substance dependence associated with psychotropic medications among the elderly, women and children: Review and analysis of the literature. Quebec: Ministère de la santé et des services sociaux.
17. Cohen, D., & Karsenty, S. (1998). Représentations sociales des effets secondaires des anxiolytiques: Une étude comparative Québec-France [Social representations of the side effects of anxiolytics: A Quebec-France comparative study]. Montreal: University of Montreal (GRASP).
18. Cohen, D., McCubbin, M., Collin, J., & Pérodeau, G. (2001). Medications as social phenomena. Health, 5, 441-469.
19. Collin, J. (1999). Rationalité et irrationalité à l'origine des mésusages des médicaments [Rationality and irrationality at the origin of medication misuse]. Actualité et Dossiers en Santé Publique, 27, 55-58.
20. Collin, J., Damestoy, N., & Lalande, R. (1999). La construction d'une rationalité: Les médecins face à la prescription de psychotropes aux personnes âgées [The construction of a rationality: Physicians faced with prescription to elderly persons]. Sciences Sociales et Santé, 17(2), 31-50.
21. Colvez, A., Carrière, I., Castex, A., & Favier, F. (2002). Recherche d'une typologie des consommations médicamenteuses des personnes âgées vivant à domicile [In search of a typology of drugs used by the aged living in the community]. Revue d'Épidemiologie et Santé Publique, 50, 121-133.
22. Cooper, J. W. (1994). Drug-related problems in the elderly patient. Generations-Journal of the American Society on Aging, 28(2), 19-27.
23. Damestoy, N., Collin, J., & Lalande, R. (1999). Prescribing psychotropic medication for elderly patients: Some physicians' perspectives. Canadian Medical Association Journal, 161, 143-145.
24. Dealberto, M. J., McAvay, G. J., Seeman, T., & Berkman, L. (1997). Psychotropic drug use and cognitive decline among older men and women. International Journal of Geriatric Psychiatry, 12, 567-574.
25. Ebly, E. M., Hogan, D. B., & Fung, T. S. (1997). Potential adverse outcomes of psychotropic and narcotic drug use in Canadian seniors. Journal of Clinical Epidemiology, 50, 857-863.
26. Ettore, E., Klaukka, T., & Riska, E. (1994). Psychotropic drugs: Long-term use, dependency, and the gender factor. Social Science and Medicine, 39, 1667-1673.
27. Ettore, E., & Riska, E. (2001). Long-term users of psychotropic drugs: Embodying masculinized stress and feminized nerves. Substance Use & Misuse, 36, 1187-1211.
28. Fernandez, L., & Cassagne-Pinel, C. (2001). Addiction aux benzodiazépines et symptomatologie anxieuse et dépressive chez les sujets âgés [Addiction to benzodiazepines and anxiety symptomatology]. L'Encéphale, 27, 459-474.
29. Finlayson, R. E. (1998). Prescription drug dependence in the elderly: The clinical pathway to recovery. Journal of Mental Health and Aging, 4, 233-249.
30. Glantz, M. (1981). Prediction of elderly drug abuse. Journal of Psychoactive Drugs, 13, 117-126.
31. Glazer, G. B., & Zawadski, R. T. (1981). Use of psychotropic drugs among the aged revisited. Journal of Psychoactive Drugs, 13, 195-198.
32. Gleason, P. P., Schultz, R., Smith, N. L., Newsom, J. T., Kroboth, F. J., & Psaty, B. M. (1998). Correlates and prevalence of benzodiazepine use in community-dwelling elders. Journal of General Internal Medicine, 13, 243-250.
33. Grymonpre, R. E., Badger, M., Tabisz, E., Jacyk, W. R., & Powell, C. (1996). The development of a prescription drug dependence screen for older adults. The Canadian Journal of Hospital Pharmacy, 49(1), 7-12.
34. Habraken, H., Soenen, K., Blondeel, L., Van Elsen, J., Bourda, J., Coppens, E., & Willeput M. (1997). Gradual withdrawal from benzodiazepines in residents of homes for the elderly: Experience and suggestions for future research. European Journal of Clinical Pharmacology, 51, 355-358.
35. Halperin, D. A., & Glick, J. (2003). Collectors, accumulators, hoarders, and hoarding perspectives. Addictive Disorders and Their Treatment, 2(2), 47-51.
36. Hanlon, J. T., Horner, R. D., Schmader, K. E., Fillenbaum, G. G., Lewis, I. K., Wall Jr., W. E., Landerman, L. R., Pieper, C. F., Blazer, D. G., & Cohen, H. J. (1998). Pharmacoepidemiology and drug utilization: Benzodiazepine use and cognitive function among community-dwelling elderly. Clinical Pharmacology Therapeutics, 64, 684-692.
37. Hazzard, W. R., Blass, J. P., Ettinger, W. H., Halter, J. B., & Ouslander, J. G. (Eds.). (1999). Principles of geriatric medicine and gerontology. Toronto: McGraw-Hill.
38. Health Canada. (1994). Canada's Alcohol and Other Drugs Survey. Ottawa: Author.
39. Helman, C. G. (1981) Tonic, fuel and food: Social and symbolic aspects of long-term use of psychotropic drugs. Social Science & Medicine, 15B, 521-533.
40. Hemmelgarn, S. R., Huang, A., Boivin, J. F., & Pinard, G. (1997). Benzodiazepine use and the risk of motor vehicle crash in the elderly. Journal of the American Medical Association, 278(1), 27-31.
41. Hulten, R., Van Bakker, A. B., Lodder, A. C, Teeuw, K. B., Bakker, A., & Leufkens, H. G. (2003). The impact of attitudes and beliefs on length of benzodiazepine use: A study among inexperienced and experiences benzodiazepine users. Social Science & Medicine, 56, 1345-1354.
42. Isacson, D. (1997). Long-term benzodiazepine use: Factors of importance and the development of individual use patterns over time - a 13-year follow-up in a Swedish community. Social Science and Medicine, 44, 1871-1881.
43. Isacson, D., Carsjo, K., Bergman, U., & Blackburn, J. L. (1992). Long-term use of benzodiazepines in a Swedish community: An eight-year follow-up. Journal of Clinical Epidemiology, 45, 429-436.
44. Jenkins, B. L. (1976). A case against "sleepers." Journal of Gerontological Nursing, 2(2), 10-13.
45. Jorm, A. F., Grayson, D., Creasey, H., Waite, L., & Broe, G. A. (2000). Long-term benzodiazepine use by elderly people living in the community. Australian and New Zealand Journal of Public Health, 24(1), 7-10.
46. Kupfer, D. J., & Reynolds, C. F. (1997). Management of insomnia. New England Journal of Medicine, 336, 341-346.
47. Lader, M. H. (1999). Limitations on the use of benzodiazepines in anxiety and insomnia: Are they justified? European Journal of Neuropsychopharmacology, 9(suppl 6), S399-S405.
48. Lagnaoui, R., Bégaud, B., Moore, N., Chaslerie, A., Fourrier, A., Letenneur, L., Dartigues, J. F., & Moride, Y. (2002). Benzodiazepine use and risk of dementia: A nested case-control study. Journal of Clinical Epidemiology, 55, 314-318.
49. Larson, E. B., Kukull, W. A., Buchner, D., Reifler, B. V. (1987). Adverse drug reactions associated with global cognitive impairment in elderly persons. Annals in Internal Medicine, 107, 169-173.
50. Lefrançois, R. (1997). Sociologie du vieillissement [Sociology of aging]. In R. Hébert & M. Arcand (Eds.), Précis pratique de gériatrie [Practical overview of geriatrics] (2nd ed., pp. 47-59). Québec: Bibliotheque Nationale du Québec.
51. Mah, L., & Upshur, R. E. G. (2002). Long term benzodiazepine use for insomnia in patients over the age of 60: Discordance of patient and physician perceptions. Bio Med Central Family Practice, 3, 9.
52. McInnes, E., & Powell, J. (1994). Drug and alcohol referrals: Are elderly substance abuse diagnoses referrals being missed? British Medical Journal, 308, 444-446.
53. McLeod, P. J., Hung, A. R., Tamblyn, A. R., & Gayton, D. C. (1997). Defining inappropriate practice in prescribing for elderly people: A national consensus panel. Canadian Medical Association Journal, 156, 385-391.
54. McMahon, A. L. (1993). Substance abuse among the elderly. Nurse Practitioner Forum, 4, 231-238.
55. Medawar, C. (1997). The antidepressant web. International Journal of Risk & Safety in Medicine, 10, 75-126.
56. Merlo, J., Östergren, P. O., Mansson, N. O., Hanson, B. S., Ranstam, J., Blennow, G., Isacsson, S. O., & Melander, A. (2000). Mortality in elderly men with low psychosocial coping ressources using anxiolytic-hypnotic drugs. Scandinavian Journal of Public Health, 28, 294-297.
57. Miller, N. S., Belkin, B. M., & Gold, M. S. (1991). Alcohol and drug dependence among the elderly: Epidemiology, diagnosis, and treatment. Comprehensive Psychiatry, 32, 153-165.
58. Miller, N. S., & Mahler, J. C. (1991). Addiction to and dependence on benzodiazepine: Diagnostic confusion in clinical practice and research studies. Journal of Substance abuse and Treatment, 8, 61-67.
59. Muhr T. (1997). ATLAS.TI Visual qualitative data analysis management model building in education, research & business. Short User's Manual. Berlin: Scientific Software Development. (http://www.atlasti.de).
60. Murphy, S., & Tyrer, P. (1991). A double-blind comparison of the effects of gradual withdrawal of lorazepam, diazepam and bromazepam in benzodiazepine dependence. British Journal of Psychiatry, 158, 511-516.
61. Murrey, J., William, P., & Clare, A. (1982). Health and social characteristics of long-term psychotropic drug takers. Social Science and Medicine, 16, 1595-1598.
62. Ohayon, M., Caulet, M., & Lemoine, P. (1996). Aging, sleep habits and psychotropic drug consumption in a general French population. Encephale, 22, 337-350.
63. Ondus, K. A., Hujer, M. E., Mann, A. E., & Mion, L. C. (1999). Substances abuse and the hospitalized elderly. Orthopaedic Nursing, 18(4), 27-34.
64. Paterniti, S., Dufouil, C., & Alpérovitch, A. (2002). Long-term benzodiazepine use and cognitive decline in the elderly: The epidemiology of vascular aging study. Journal of Clinical Psychopharmacology, 22, 285-293.
65. Pelissolo, A., & Bisserbe, J. C. (1994). Dépendance aux benzodiazépines: Aspects cliniques et biologiques [Benzodiazepine dependence: Clinical and biological aspects]. L'Encephale, 20, 147-157.
66. Pérodeau, G., & Galbaud du Fort, G. (2000). Psychotropic drug use and the relation between social support, life events, and mental health in the elderly. Journal of Applied Gerontology, 19(1), 23-41.
67. Pérodeau, G., King, S., & Ostoj, M. (1992). Stress and psychotropic drug use among the elderly: An exploratory model. The Canadian Journal of Aging, 11, 347-369.
68. Pérodeau, G., Voyer, P., Paradis, I., Collin, J., Lauzon, S., & Ducharme, F. (2003). Recherche d'informations sur les psychotropes par les personnes âgées consommatrices: les professionnels de la santé, les proches et les médias [Psychotropic drugs information seeking behaviors by elderly users: Health care providers, relatives and medias]. Vie et Vieillissement, 2(3), 37-44.
69. Petrovic, M., Vandierendonck, A., Mariman, A., & Maele, G. V. (2002). Personality traits and socio-epidemiological status of hospitalized elderly benzodiazepine users. International Journal of Gerontological Psychiatry, 17, 733-738.
70. Pimplott, N. J. G., Hux, J. E., Wilson, L. M., Kahan, M., Li, C., & Rosser, W. (2003). Educating physicians to reduce benzodiazepine use by elderly patients: A randomized controlled trial. Canadian Medical Association Journal, 168(7), 835-839.
71. Pinksen, H., & Suljaga-Petchel, K. (1984). Use of benzodiazepine in primary-care geriatric patients. Journal of the American Geriatric Society, 32, 595-597.
72. Ray, W. A. (1992). Psychotropic drugs and injuries among the elderly: A review. Journal of Clinical Psychopharmacology, 12, 386-396.
73. Ryan, A. A. (1999). Medication compliance and older people: Review of the literature. International Journal of Nursing Studies, 36, 153-162
74. Salzman, C. (1995). Medication compliance in the elderly. Journal of Clinical Psychiatry, 56(supp. 1), 18-23.
75. Salzman, C., Fisher, J., Nobel, K., Glassman, R., Wolfson, A., & Kelley, M. (1992). Cognitive improvement following benzodiazepine discontinuation in elderly nursing home residents. International Journal of Geriatric Psychiatry, 7, 89-93.
76. Simonson, W. (1984). Medications & the elderly. A guide for promoting proper use. Rockville, MD: Aspen.
77. Sleath, B., Svarstad, B., & Roter, D. (1997). Physician vs. patient initiation of psychotropic prescribing in primary care settings: A content analysis of audiotapes. Social Science and Medicine, 444, 541-548.
78. Spagnoli, A., Ostino, G., Borga, A. D., D'Ambrosio, R., Magiorotti, P., Todisco, E., Prattichizzo, W., Pia, L., & Comelli, M. (1989). Drug compliance and undereported drugs in the elderly. Journal of the American Geriatric Society, 37, 92-98.
79. Stevenson, G., Kellogg, L. A., Ernst, V. I., & Whinney, P. P. (1989). Medication use and elderly people. Senior drug action program. British Columbia: Ministry of Health.
80. Straand, J., & Rockstad, K. (1997). General practitioners' prescribing patterns of benzodiazepine hypnotics: Are elderly patients at particular risk for overprescribing? Scandinavian Journal of Primary Health Care, 15(1), 16-21.
81. Tabisz, E. M., Jacyk, W. R., Fuchs, D., & Grymonpre, R. (1991). Chemical dependency in the elderly: The enabling factor. Canadian Journal on Aging, 12, 78-88.
82. Tamblyn, R. M., McLeod, P. J., Abrahamowicz, M., Monette, J., Gayton, D. C., Dauphinee, W. D., Grad R. M., Huang, A. R., Lissac, L. M., Schnarch, B. S., & Snell, L. S. (1994). Questionable prescribing for elderly patients in Quebec. Canadian Medical Association Journal, 150, 1801-1809.
83. Thomson, M., & Smith, W. A. (1995). Prescribing benzodiazepines for noninstitutionalized elderly. Canadian Family Physician, 41, 792-798.
84. Tromp, A. M., Pluijm, S. M., Smit, J. H., Deeg, D. J., Bouter, L. M., & Lips, P. (2001). Fall-risk screening test: A prospective study on predictors for falls in community-dwelling elderly. Journal of Clinical Epidemiology, 54, 837-844.
85. Tyrer, P., Murphy, S., & Riley, Z. P. (1990). The Benzodiazepine withdrawal symptom questionnaire. Journal of Affective Disorders, 19, 53-61.
86. Van Broekhoven, F., Kan, C. C., & Zitman, F. G. (2002). Dependence potential of antidepressants compared to benzodiazepines. Progress in Neuropsychopharmacology and Biological Psychiatry, 26(5), 939-943.
87. Van der Waals, F. J., Mohrs, J., & Foets, M. (1993). Sex differences among recipients of benzodiazepines in Dutch general practice. British Medical Journal, 307, 363-366.
88. Ville de Laval. (2003). Les statistiques [The statistics]. Available: http://www.ville.laval.qc.ca/
89. Volkow, N. D., Ding, Y. S., Fowler, J. S., Wang, G. J., Logan, J., Gatley, J. S., Dewey, S., Ashby, C., Liebermann, J., & Hitzemann, R. (1995). Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain. Archives of General Psychiatry, 52(6), 456-463.
90. Voyer, P. (2001). La relation entre la santé mentale et la consommation de psychotropes chez des aînés vivant dans la communauté [the relationship between mental health and psychotropics among elderly living in the community]. Doctoral thesis, Faculté des sciences infirmières. Montreal: Université de Montréal.
91. Voyer, P., & Martin, L. S. (2003). Improving geriatric mental health nursing care: Making a case for going beyond psychotropic medications. International Journal of Mental Health Nursing, 12(1), 11-21.
92. Voyer, P., McCubbin, M., Préville, M., & Boyer, R. (2003). Factors in duration of anxiolytic, sedative, and hypnotic drug use in the elderly. Canadian Journal of Nursing Research, 35(4), 126-149.
93. Voyer, P., Richard, L., & Dupont, L. (2001). Changer une habitude pour gagner en latitude [Changing a habit to gain latitude]. Canadian Nurse, 2(8), 11-15.
94. Wancata, J., Benda, N., Meise, U., & Müller, C. (1997). Psychotropic drug intake in residents newly admitted to nursing homes. Psychopharmacology, 134, 115-120.
95. Whitcup, S. M., & Miller, F. (1987). Unrecognized drug dependence in psychiatrically hospitalized elderly patients. Journal of the American Geriatrics Society, 35, 297-301.
96. Woods, J. H., & Winger, G. (1995). Current benzodiazepine issues. Psychopharmacology, 118, 107-115.